Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven K Dower

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Thorax|August 10, 2007
Pathological networking: a new approach to understanding COPDIan Sabroe, Lisa C Parker, Peter M A Calverley, et al.
Infection and Immunity|June 24, 2003
Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strainsAlison C Pridmore, Gary A Jarvis, Constance M John, et al.
Journal of Leukocyte Biology|October 26, 2005
Endotoxin tolerance induces selective alterations in neutrophil functionLisa C Parker, Elizabeth C Jones, Lynne R Prince, et al.
The Journal of Antimicrobial Chemotherapy|November 3, 2006
Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibioticsLisa J Moore, Andrea M Gilbey, Christopher G Dowson, et al.
Nature Reviews. Immunology|December 23, 2006
Identifying and hurdling obstacles to translational researchIan Sabroe, David H Dockrell, Stefanie N Vogel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Toll-like receptors in health and disease: complex questions remainIan Sabroe, Robert C Read, Moira K B Whyte, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2005
Agonists of toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytesGavin E Morris, Moira K B Whyte, Gillian F Martin, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2006
Targeting the networks that underpin contiguous immunity in asthma and chronic obstructive pulmonary diseaseIan Sabroe, Lisa C Parker, David H Dockrell, et al.
Plos Computational Biology|November 4, 2024
A mechanistic model of in vitro plasma activation to evaluate therapeutic kallikrein-kinin system inhibitorsAlireza Rezvani-Sharif, Hadi Lioe, Steven K Dower, et al.
Cardiovascular Research|August 16, 2005
Interleukin-1 receptor antagonist alters the response to vessel wall injury in a porcine coronary artery modelAllison C Morton, Nadine D Arnold, Julian Gunn, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Thorax|August 10, 2007
Pathological networking: a new approach to understanding COPDIan Sabroe, Lisa C Parker, Peter M A Calverley, et al.
Infection and Immunity|June 24, 2003
Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strainsAlison C Pridmore, Gary A Jarvis, Constance M John, et al.
Journal of Leukocyte Biology|October 26, 2005
Endotoxin tolerance induces selective alterations in neutrophil functionLisa C Parker, Elizabeth C Jones, Lynne R Prince, et al.
The Journal of Antimicrobial Chemotherapy|November 3, 2006
Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibioticsLisa J Moore, Andrea M Gilbey, Christopher G Dowson, et al.
Nature Reviews. Immunology|December 23, 2006
Identifying and hurdling obstacles to translational researchIan Sabroe, David H Dockrell, Stefanie N Vogel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Toll-like receptors in health and disease: complex questions remainIan Sabroe, Robert C Read, Moira K B Whyte, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2005
Agonists of toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytesGavin E Morris, Moira K B Whyte, Gillian F Martin, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2006
Targeting the networks that underpin contiguous immunity in asthma and chronic obstructive pulmonary diseaseIan Sabroe, Lisa C Parker, David H Dockrell, et al.
Plos Computational Biology|November 4, 2024
A mechanistic model of in vitro plasma activation to evaluate therapeutic kallikrein-kinin system inhibitorsAlireza Rezvani-Sharif, Hadi Lioe, Steven K Dower, et al.
Cardiovascular Research|August 16, 2005
Interleukin-1 receptor antagonist alters the response to vessel wall injury in a porcine coronary artery modelAllison C Morton, Nadine D Arnold, Julian Gunn, et al.
Pageof 5